503 related articles for article (PubMed ID: 27309057)
1. Recombinant Turkey Herpesvirus-AI Vaccine Virus Replication in Different Species of Waterfowl.
Palya V; Kovács EW; Tatár-Kis T; Felföldi B; Homonnay ZG; Mató T; Sato T; Gardin Y
Avian Dis; 2016 May; 60(1 Suppl):210-7. PubMed ID: 27309057
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of a Recombinant Turkey Herpesvirus H5 Vaccine Against Challenge With H5N1 Clades 1.1.2 and 2.3.2.1 Highly Pathogenic Avian Influenza Viruses in Domestic Ducks (Anas platyrhynchos domesticus).
Pantin-Jackwood MJ; Kapczynski DR; DeJesus E; Costa-Hurtado M; Dauphin G; Tripodi A; Dunn JR; Swayne DE
Avian Dis; 2016 Mar; 60(1):22-32. PubMed ID: 26953940
[TBL] [Abstract][Full Text] [Related]
3. Protective Efficacy of Recombinant Turkey Herpes Virus (rHVT-H5) and Inactivated H5N1 Vaccines in Commercial Mulard Ducks against the Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.2.1 Virus.
Kilany WH; Safwat M; Mohammed SM; Salim A; Fasina FO; Fasanmi OG; Shalaby AG; Dauphin G; Hassan MK; Lubroth J; Jobre YM
PLoS One; 2016; 11(6):e0156747. PubMed ID: 27304069
[TBL] [Abstract][Full Text] [Related]
4. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.
Kapczynski DR; Esaki M; Dorsey KM; Jiang H; Jackwood M; Moraes M; Gardin Y
Vaccine; 2015 Feb; 33(9):1197-205. PubMed ID: 25613723
[TBL] [Abstract][Full Text] [Related]
5. Vaccine Protection of Turkeys Against H5N1 Highly Pathogenic Avian Influenza Virus with a Recombinant Turkey Herpesvirus Expressing the Hemagglutinin Gene of Avian Influenza.
Kapczynski DR; Dorsey K; Chrzastek K; Moraes M; Jackwood M; Hilt D; Gardin Y
Avian Dis; 2016 Jun; 60(2):413-7. PubMed ID: 27309280
[TBL] [Abstract][Full Text] [Related]
6. Protection Afforded by a Recombinant Turkey Herpesvirus-H5 Vaccine Against the 2014 European Highly Pathogenic H5N8 Avian Influenza Strain.
Steensels M; Rauw F; van den Berg T; Marché S; Gardin Y; Palya V; Lambrecht B
Avian Dis; 2016 May; 60(1 Suppl):202-9. PubMed ID: 27309056
[TBL] [Abstract][Full Text] [Related]
7. Construction of a recombinant duck enteritis virus (DEV) expressing hemagglutinin of H5N1 avian influenza virus based on an infectious clone of DEV vaccine strain and evaluation of its efficacy in ducks and chickens.
Wang J; Ge A; Xu M; Wang Z; Qiao Y; Gu Y; Liu C; Liu Y; Hou J
Virol J; 2015 Aug; 12():126. PubMed ID: 26263920
[TBL] [Abstract][Full Text] [Related]
8. Pekin and Muscovy ducks respond differently to vaccination with a H5N1 highly pathogenic avian influenza (HPAI) commercial inactivated vaccine.
Cagle C; To TL; Nguyen T; Wasilenko J; Adams SC; Cardona CJ; Spackman E; Suarez DL; Pantin-Jackwood MJ
Vaccine; 2011 Sep; 29(38):6549-57. PubMed ID: 21771626
[TBL] [Abstract][Full Text] [Related]
9. Experimental and Field Results Regarding Immunity Induced by a Recombinant Turkey Herpesvirus H5 Vector Vaccine Against H5N1 and Other H5 Highly Pathogenic Avian Influenza Virus Challenges.
Gardin Y; Palya V; Dorsey KM; El-Attrache J; Bonfante F; Wit Sd; Kapczynski D; Kilany WH; Rauw F; Steensels M; Soejoedono RD
Avian Dis; 2016 May; 60(1 Suppl):232-7. PubMed ID: 27309060
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a recombinant HVT-H5 vaccine against challenge with two genetically divergent Indonesian HPAI H5N1 strains.
Soejoedono RD; Murtini S; Palya V; Felföldi B; Mató T; Gardin Y
Avian Dis; 2012 Dec; 56(4 Suppl):923-7. PubMed ID: 23402113
[TBL] [Abstract][Full Text] [Related]
11. Immune responses and protection against H5N1 highly pathogenic avian influenza virus induced by the Newcastle disease virus H5 vaccine in ducks.
Ferreira HL; Pirlot JF; Reynard F; van den Berg T; Bublot M; Lambrecht B
Avian Dis; 2012 Dec; 56(4 Suppl):940-8. PubMed ID: 23402116
[TBL] [Abstract][Full Text] [Related]
12. Differences in pathogenicity, response to vaccination, and innate immune responses in different types of ducks infected with a virulent H5N1 highly pathogenic avian influenza virus from Vietnam.
Cagle C; Wasilenko J; Adams SC; Cardona CJ; To TL; Nguyen T; Spackman E; Suarez DL; Smith D; Shepherd E; Roth J; Pantin-Jackwood MJ
Avian Dis; 2012 Sep; 56(3):479-87. PubMed ID: 23050463
[TBL] [Abstract][Full Text] [Related]
13. Further evidence of antigenic drift and protective efficacy afforded by a recombinant HVT-H5 vaccine against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains.
Rauw F; Palya V; Van Borm S; Welby S; Tatar-Kis T; Gardin Y; Dorsey KM; Aly MM; Hassan MK; Soliman MA; Lambrecht B; van den Berg T
Vaccine; 2011 Mar; 29(14):2590-600. PubMed ID: 21292007
[TBL] [Abstract][Full Text] [Related]
14. Expression of HA of HPAI H5N1 virus at US2 gene insertion site of turkey herpesvirus induced better protection than that at US10 gene insertion site.
Gao H; Cui H; Cui X; Shi X; Zhao Y; Zhao X; Quan Y; Yan S; Zeng W; Wang Y
PLoS One; 2011; 6(7):e22549. PubMed ID: 21818336
[TBL] [Abstract][Full Text] [Related]
15. Tissue tropism of highly pathogenic avian influenza virus subtype H5N1 in naturally infected mute swans (Cygnus Olor ), domestic geese (Aser Anser var. domestica), pekin ducks (Anas platyrhynchos) and mulard ducks ( Cairina moschata x anas platyrhynchos).
Szeredi L; Dán A; Pálmai N; Ursu K; Bálint A; Szeleczky Z; Ivanics E; Erdélyi K; Rigó D; Tekes L; Glávits R
Acta Vet Hung; 2010 Mar; 58(1):133-45. PubMed ID: 20514747
[TBL] [Abstract][Full Text] [Related]
16. Vaccination of domestic ducks against H5N1 HPAI: a review.
Pantin-Jackwood MJ; Suarez DL
Virus Res; 2013 Dec; 178(1):21-34. PubMed ID: 23916865
[TBL] [Abstract][Full Text] [Related]
17. H5-based DNA constructs derived from selected highly pathogenic H5N1 avian influenza virus induce high levels of humoral antibodies in Muscovy ducks against low pathogenic viruses.
Guionie O; Niqueux E; Amelot M; Bougeard S; Jestin V
Virol J; 2014 Apr; 11():74. PubMed ID: 24762011
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effectiveness of rHVT-H5, inactivated H5 and rHVT-H5 with inactivated H5 prime/boost vaccination regimes in commercial broiler chickens carrying MDAs against HPAI H5N1 clade 2.2.1 virus.
Kilany WH; Hassan MK; Safwat M; Mohammed S; Selim A; VonDobschuetz S; Dauphin G; Lubroth J; Jobre Y
Avian Pathol; 2015 Oct; 44(5):333-41. PubMed ID: 26023824
[TBL] [Abstract][Full Text] [Related]
19. Prime-boost vaccination with recombinant H5-fowlpox and Newcastle disease virus vectors affords lasting protection in SPF Muscovy ducks against highly pathogenic H5N1 influenza virus.
Niqueux E; Guionie O; Amelot M; Jestin V
Vaccine; 2013 Aug; 31(38):4121-8. PubMed ID: 23845804
[TBL] [Abstract][Full Text] [Related]
20. Principles for vaccine protection in chickens and domestic waterfowl against avian influenza: emphasis on Asian H5N1 high pathogenicity avian influenza.
Swayne DE
Ann N Y Acad Sci; 2006 Oct; 1081():174-81. PubMed ID: 17135509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
